Market Snapshot
S&P Futures
4,228
Dow Futures
33,685
Nasdaq Futures
13,251.75
NovaBay Pharmaceuticals, Inc. (NBY) stock rallied over 1.94% intraday to trade at $0.26 a share on AMEX. The stock opened with a gain of 0.00% at $0.257 and touched an intraday high of $0.27, rising 0.00% against the last close of $0.26. The stock went to a low of $0.25 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-18 | $0.257 | $0.27 | $0.25 | $0.263 | 159,173 |
2022-08-17 | $0.26 | $0.27 | $0.25 | $0.26 | 180,300 |
2022-08-16 | $0.27 | $0.28 | $0.24 | $0.26 | 973,100 |
2022-08-15 | $0.27 | $0.28 | $0.26 | $0.27 | 215,100 |
2022-08-12 | $0.3 | $0.3 | $0.26 | $0.28 | 873,100 |
2022-08-11 | $0.31 | $0.32 | $0.29 | $0.31 | 893,600 |
2022-08-10 | $0.3 | $0.32 | $0.29 | $0.31 | 627,900 |
2022-08-09 | $0.31 | $0.34 | $0.3 | $0.3 | 1,753,300 |
2022-08-08 | $0.28 | $0.36 | $0.28 | $0.34 | 6,085,300 |
2022-08-05 | $0.27 | $0.29 | $0.27 | $0.28 | 703,000 |
Employees-
Beta2.83
Sales or Revenue9.24 Million
5Y Sales Change-6.7%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryPharmaceuticals
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
NovaBay Pharmaceuticals, Inc. (AMEX: NBY) stock price is $0.26 as of the last check on Thursday, August 18. During the trading session, NBY stock reached the peak price of $0.27 while $0.25 was the lowest point it dropped to.
The AMEX listed NBY is part of Pharmaceuticals industry that operates in the broader Health Care sector. NovaBay Pharmaceuticals, Inc. , a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally.
Mr. Justin M. Hall Esq.
Pres, CEO, Gen. Counsel, Chief Compliance Officer, Corp. Sec. & Director
Mr. Andrew D. Jones
CFO & Treasurer
Dr. Audrey Kunin M.D.
Chief Product Officer & Director
Dr. Jeffrey Kunin M.D.
Pres of DERMAdoctor
NBY stock traded closed the last session at $0.263, which is $0 or 1.94% lower than its previous close of $0.26. NBY's current trading price is 53.77% lower than its 52-week high of $0.77 where as its distance from 52-week low of 0.17% is -65.83%.
Number of NBY employees currently stands at -. NBY operates from 2000 Powell Street, Suite 1150, EmeryVille, CA 94608, United States.
Official Webiste of $NBY is: https://novabay.com
NBY could be contacted at NBY operates from 2000 Powell Street, Suite 1150, EmeryVille, CA 94608, United States, or at phone #510 899 8800 and can also be accessed through its website.
NBY stock volume for the day was 165,563 shares while in the previous session number of NBY shares traded was 159,173 . The average number of NBY shares traded daily for last 3 months was 767.35 Thousands.
The percentage change in NBY stock occurred in the recent session was 1.94% while the dollar amount for the price change in NBY stock was $0.
In the recent session, the day high for NBY stock was $0.27 while the low for NBY stock touched on the day was $0.25.
The market value of NBY currently stands at 15.13 Million with its latest stock price at $0.26 and 52.73 Million of its shares outstanding.